New hope for easing chemo sickness in advanced breast cancer
NCT ID NCT07132749
Summary
This study is observing how well a drug called NEPA prevents nausea and vomiting in people with advanced breast cancer who are receiving a specific chemotherapy called T-DXd. It will follow 100 patients to see how effective and safe NEPA is at controlling these side effects over several days after each chemotherapy dose. The goal is to improve patients' quality of life during their cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH HER2-POSITIVE ADVANCED BREAST CANCER TREATED WITH T-DXD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Samsung Medical Center
Seoul, Gangnam-gu, 06355, South Korea
Conditions
Explore the condition pages connected to this study.